title: Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice.
abstract: Obesity is an important risk factor for colon cancer in humans, and numerous studies have shown that a high fat diet enhances colon cancer development. As both increased adiposity and high fat diet can promote tumorigenesis, we examined the effect of diet-induced obesity, without ongoing high fat diet, on colon tumor development. C57BL/6J male mice were fed regular chow or high fat diet for 8 weeks. Diets were either maintained or switched resulting in four experimental groups: regular chow (R), high fat diet (H), regular chow switched to high fat diet (RH), and high fat diet switched to regular chow (HR). Mice were then administered azoxymethane to induce colon tumors. Tumor incidence and multiplicity were dramatically smaller in the R group relative to all groups that received high fat diet at any point. The effect of obesity on colon tumors could not be explained by differences in aberrant crypt foci number. Moreover, diet did not alter colonic expression of pro-inflammatory cytokines tumor necrosis factor-α, interleukin-6, interleukin-1β, and interferon-γ, which were measured immediately after azoxymethane treatment. Crypt apoptosis and proliferation, which were measured at the same time, were increased in the HR relative to all other groups. Our results suggest that factors associated with obesity - independently of ongoing high fat diet and obesity - promote tumor development because HR group animals had significantly more tumors than R group, and these mice were fed the same regular chow throughout the entire carcinogenic period. Moreover, there was no difference in the number of aberrant crypt foci between these groups, and thus the effect of obesity appears to be on subsequent stages of tumor development when early preneoplastic lesions transition into adenomas.
authors.affiliation: Division of Digestive Diseases, David Geffen School of Medicine at University of California in Los Angeles, Los Angeles, CA, USA.
authors.forename: Iina
authors.initials: I
authors.lastname: Tuominen
authors.forename: Leina
authors.initials: L
authors.lastname: Al-Rabadi
authors.forename: Dimitris
authors.initials: D
authors.lastname: Stavrakis
authors.forename: Iordanis
authors.initials: I
authors.lastname: Karagiannides
authors.forename: Charalabos
authors.initials: C
authors.lastname: Pothoulakis
authors.forename: James M
authors.initials: JM
authors.lastname: Bugni
mesh_terms: D058739:Aberrant Crypt Foci / Q000139:chemically induced / Q000150:complications* / Q000276:immunology / Q000473:pathology; D000236:Adenoma / Q000139:chemically induced / Q000150:complications* / Q000276:immunology / Q000473:pathology; D000818:Animals; D001397:Azoxymethane; D003106:Colon / Q000276:immunology / Q000473:pathology*; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000150:complications* / Q000276:immunology / Q000473:pathology; D059305:Diet, High-Fat; D007371:Interferon-gamma / Q000276:immunology; D053583:Interleukin-1beta / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009765:Obesity / Q000150:complications* / Q000276:immunology / Q000473:pathology; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D053583:Interleukin-1beta; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D001397:Azoxymethane
references.citation: Int J Cancer. 2009 May 1;124(9):2226-30
references.pmid: 19123482
references.citation: Gastroenterology. 2012 Apr;142(4):762-72
references.pmid: 22245665
references.citation: Gut. 2008 Nov;57(11):1531-8
references.pmid: 18676419
references.citation: Gastroenterology. 2012 Sep;143(3):741-753.e4
references.pmid: 22677195
references.citation: Carcinogenesis. 2001 Nov;22(11):1871-5
references.pmid: 11698351
references.citation: Cell. 1990 Jun 1;61(5):759-67
references.pmid: 2188735
references.citation: Nature. 2009 Jan 22;457(7228):480-4
references.pmid: 19043404
references.citation: Carcinogenesis. 2012 Mar;33(3):702-7
references.pmid: 22223845
references.citation: Int J Oncol. 2007 Oct;31(4):837-42
references.pmid: 17786315
references.citation: J Natl Cancer Inst. 2004 Apr 7;96(7):546-53
references.pmid: 15069117
references.citation: Cancer Prev Res (Phila). 2009 Jan;2(1):60-9
references.pmid: 19139019
references.citation: Int J Cancer. 2011 Aug 1;129(3):528-35
references.pmid: 20886595
references.citation: Nature. 2006 Dec 14;444(7121):860-7
references.pmid: 17167474
references.citation: Carcinogenesis. 2004 May;25(5):821-5
references.pmid: 14729596
references.citation: Eur J Endocrinol. 1998 Dec;139(6):654-61
references.pmid: 9916873
references.citation: Cancer Res. 1997 Jan 15;57(2):253-8
references.pmid: 9000564
references.citation: Int J Cancer. 2004 Mar;109(1):149-52
references.pmid: 14735482
references.citation: Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):1013-5
references.pmid: 8959325
references.citation: Cancer Sci. 2011 Jan;102(1):79-87
references.pmid: 20946475
references.citation: PLoS One. 2010 Aug 16;5(8):e12191
references.pmid: 20808947
references.citation: Mol Carcinog. 2008 Sep;47(9):667-77
references.pmid: 18240295
references.citation: Obes Rev. 2010 Jan;11(1):19-30
references.pmid: 19538439
references.citation: Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1150-6
references.pmid: 17194898
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2524-31
references.pmid: 22056504
references.citation: Lancet. 2008 Feb 16;371(9612):569-78
references.pmid: 18280327
references.citation: Nat Rev Cancer. 2008 Jun;8(6):415-24
references.pmid: 18480839
references.citation: J Nutr Biochem. 2012 Oct;23(10):1207-13
references.pmid: 22209007
references.citation: J Clin Invest. 1995 May;95(5):2409-15
references.pmid: 7738205
references.citation: Dig Dis Sci. 2012 Jul;57(7):1866-74
references.pmid: 22373862
references.citation: Eur J Nutr. 2008 Apr;47(3):161-70
references.pmid: 18480976
references.citation: Int J Oncol. 2003 Jan;22(1):145-50
references.pmid: 12469197
references.citation: Cancer Res. 2006 May 15;66(10):5469-76
references.pmid: 16707476
references.citation: Pathol Int. 2011 Feb;61(2):80-7
references.pmid: 21255184
references.citation: Am J Epidemiol. 2008 Jul 1;168(1):30-7
references.pmid: 18477652
references.citation: Lipids. 1992 Oct;27(10):807-13
references.pmid: 1435100